Weiye Li MD, PhD
Professor Emeritus of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania; Physician, Drexel Eye Physicians, Philadelphia, PennsylvaniaDr. Weiye Li is an Emeritus Professor of Ophthalmology at Drexel University College of Medicine. He served as the Director of both Ophthalmic Research and Retina Services at Drexel.
Dr. Weiye Li received his medical degree from the Second Medical College of Beijing, China, and received his doctorate from the University of Pennsylvania in Philadelphia. He completed a fellowship in retina vitreous diseases at Crozer-Chester Medical Center, Upland, Pennsylvania. Dr. Li was previously Chairman of the Department of Ophthalmology at Peking Union Medical College Hospital, one of the most competitive and internationally respected medical colleges in the People's Republic of China.
Dr. Li’s basic and clinical research focuses on diabetic retinopathy and age-related macular degeneration He is widely published in the field of ophthalmology and has earned many honors and awards for his research. He is also active in many organizations, including the Association of Research in Vision and Ophthalmology.
Recent Contributions to PracticeUpdate:
- Prophylactic Laser to Decrease the Incidence of Retinal Detachment in Fellow Eyes of Idiopathic Giant Retinal Tears
- Exudative Recurrence Rates for Eyes With Inactivated Wet AMD on 12-Week Interval Dosing With Bevacizumab
- Comparative Evaluation of Anterior Segment OCT, Ultrasound Biomicroscopy, and IOP Changes After Pan-Retinal Photocoagulation by Pascal and Conventional Laser
- Disorganization of Retinal Inner Layers and Neuroretinal Dysfunction in Early Diabetic Retinopathy
- Swept-Source OCTA of the Three Capillary Plexuses and Choriocapillaris in Patients With Type 1 and Type 2 Diabetes Without Clinical Signs of Diabetic Retinopathy
- Pneumatic Retinopexy vs Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment
- 2018 Top Stories in Eye Care: Clinical Retina
- Topical Antibiotics and Intravitreal Injections
- Dilute Povidone–Iodine Prophylaxis After Intravitreal Injections
- Dorzolamide–Timolol as Adjuvant Therapy in Neovascular AMD Refractory to Anti-VEGF Treatment